Samoa Wellness Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Samoa Wellness Report.

Press releases published on July 29, 2026

Jul. 29, 2026

BrainsWay to Report Second Quarter 2026 Financial Results on August 12, 2026

Indeterminate GlobeNewswire

Jul. 29, 2026

PROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. AND APPROXIMATELY $200 MILLION CONCURRENT PRIVATE PLACEMENT TO ADVANCE BTK INHIBITOR, VT-7208, IN MULTIPLE DISEASE AREAS

Indeterminate GlobeNewswire

Jul. 29, 2026

TG Therapeutics to Host Conference Call on Second Quarter 2026 Financial Results and Business Update

Indeterminate GlobeNewswire

Jul. 29, 2026

Interest in Disability Insurance for Veterinarians Triples in 12 Months

Indeterminate GlobeNewswire

Jul. 29, 2026

uniQure Announces Second Quarter 2026 Financial Results and Provides Company Update

Indeterminate GlobeNewswire

Jul. 29, 2026

Axogen, Inc. Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Jul. 29, 2026

Anika Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Jul. 29, 2026

Ocugen Announces that the U.S. Food and Drug Administration Has Granted OCU410 Regenerative Medicine Advanced Therapy (RMAT) Designation for Treatment of Geographic Atrophy, Secondary to Dry Age-Related Macular Degeneration

Indeterminate GlobeNewswire

Jul. 29, 2026

VERAXA Biotech Strengthens Patent Portfolio to Protect Core Technology Platforms and Product Candidates

Indeterminate GlobeNewswire

Jul. 29, 2026

Silexion Therapeutics Successfully Initiates Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer at Tel Aviv Sourasky Medical Center

Indeterminate GlobeNewswire

Jul. 29, 2026

Teva Delivers Strong Q2 Results and Raises Outlook for All Three Key Innovative Brands, Reflecting Continued Execution of Its Pivot to Growth Strategy

Indeterminate GlobeNewswire

Jul. 29, 2026

Aquestive Therapeutics to Report Second Quarter 2026 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET

Indeterminate GlobeNewswire

Jul. 29, 2026

Option Care Health Announces Financial Results For The Second Quarter Ended June 30, 2026

Indeterminate GlobeNewswire

Jul. 29, 2026

Atavistik Bio Appoints Habib Dable to its Board of Directors

Indeterminate GlobeNewswire

Jul. 29, 2026

Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O’Keefe

Indeterminate GlobeNewswire

Jul. 29, 2026

OPSEU/SEFPO workers at Canadian Blood Services strike a blow against privatization

Indeterminate GlobeNewswire

Jul. 29, 2026

Bioxytran Announces Publication of Corporate Research Report by Globe Small Cap Research

Indeterminate GlobeNewswire

Jul. 29, 2026

XORTX Appoints New Director

Indeterminate GlobeNewswire

Jul. 29, 2026

Amarin Reports 2026 Second Quarter Financial Results Demonstrating Early Success of Fully Partnered International Commercial Strategy and Continued Leading U.S. Market Presence

Indeterminate GlobeNewswire

Jul. 29, 2026

Aclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026

Indeterminate GlobeNewswire